Glucose-dependent insulinotropic polypeptide (GIP): development of DP IV-resistant analogues with therapeutic potential.
Hinke
Simon A
SA
Department of Physiology, University of British Columbia, Vancouver, Canada.
Lynn
Francis
F
Ehses
Jan
J
Pamir
Nathalie
N
Manhart
Susanne
S
Kühn-Wache
Kerstin
K
Rosche
Fred
F
Demuth
Hans-Ulrich
HU
Pederson
Raymond A
RA
McIntosh
Christopher H S
CH
D000595:Amino Acid Sequence; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000188:drug therapy; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D004195:Disease Models, Animal; D005749:Gastric Inhibitory Polypeptide / Q000737:chemistry / Q000502:physiology* / Q000627:therapeutic use; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D017433:Protein Structure, Secondary; D051381:Rats
D001786:Blood Glucose; D010446:Peptide Fragments; D005749:Gastric Inhibitory Polypeptide; D018819:Dipeptidyl Peptidase 4